Miyakogusa Predicted Gene
- Lj0g3v0234389.1
BLASTP 2.2.25 [Feb-01-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= Lj0g3v0234389.1 tr|Q0E1Z1|Q0E1Z1_ORYSJ Os02g0288400 protein
OS=Oryza sativa subsp. japonica GN=Os02g0288400 PE=3
SV=,53.68,1e-18,seg,NULL; GTP BINDING / GTPASE,NULL; FAMILY NOT
NAMED,NULL,CUFF.15328.1
(330 letters)
Database: TAIR10_pep
35,386 sequences; 14,482,855 total letters
Searching..................................................done
Score E
Sequences producing significant alignments: (bits) Value
AT3G13080.4 | Symbols: ATMRP3, MRP3, ABCC3 | multidrug resistanc... 169 3e-42
AT3G13080.3 | Symbols: ATMRP3, MRP3, ABCC3 | multidrug resistanc... 169 3e-42
AT3G13080.1 | Symbols: ATMRP3, MRP3, ABCC3 | multidrug resistanc... 168 4e-42
AT3G13080.2 | Symbols: ATMRP3, MRP3, ABCC3 | multidrug resistanc... 168 4e-42
AT3G13090.1 | Symbols: ATMRP8, ABCC6, MRP8 | multidrug resistanc... 139 4e-33
AT3G13100.1 | Symbols: ATMRP7, MRP7, ABCC7 | multidrug resistanc... 125 5e-29
AT3G60160.1 | Symbols: ATMRP9, MRP9, ABCC9 | multidrug resistanc... 81 1e-15
AT1G04120.1 | Symbols: ATMRP5, MRP5, ATABCC5, ABCC5 | multidrug ... 80 2e-15
AT1G04120.2 | Symbols: MRP5 | multidrug resistance-associated pr... 80 2e-15
AT3G59140.1 | Symbols: ATMRP14, MRP14, ABCC10 | multidrug resist... 62 8e-10
AT2G47800.1 | Symbols: ATMRP4, EST3, MRP4, ABCC4 | multidrug res... 50 2e-06
>AT3G13080.4 | Symbols: ATMRP3, MRP3, ABCC3 | multidrug
resistance-associated protein 3 | chr3:4197606-4201250
REVERSE LENGTH=1120
Length = 1120
Score = 169 bits (427), Expect = 3e-42, Method: Compositional matrix adjust.
Identities = 123/340 (36%), Positives = 165/340 (48%), Gaps = 24/340 (7%)
Query: 4 ATGFFLEPXXXXXXXXXXXXXXXVAVFASWVWNKFTSYASSSAKVDGG--GSKEKTNNTL 61
+ F L+P + +F SWV K + D G S + +
Sbjct: 28 SRSFLLKPLFLRWLSGFLHSVLLLVLFFSWVRKKI--------RGDSGVTESLKDRRDFG 79
Query: 62 FSVTLFCSLGVSXXXXXXXXXXXXXWYSNGW-SEEKLVTLLDLALKMVAWGVVCACFLKG 120
F LFCSL +S WY +GW E+LV+ L L MV+WGV+ C +
Sbjct: 80 FKSALFCSLALSLLNLVLMSLSGFYWYESGWLDNEQLVSSLGFLLGMVSWGVLSICLHRC 139
Query: 121 FS---RRFPFFLFRIWCGFFLFVSCYCFAVDVVVICEKDTALPPQHVVSDVVSAIVGLFF 177
++ PF L R+W F+L VSCY VD V+ ++T +P +V D+V+ I +F
Sbjct: 140 RDCEHKKAPFLL-RLWLVFYLVVSCYSLVVDFVMYERRET-VPVHLLVFDIVAFIAAVFL 197
Query: 178 CCVGFVLKNEGGGGSNSVHEPLLKG-DSQVGNG-----KESKGSDTVTPFSSAGIFSILT 231
V VLK + + + EPLL G DS+VG ++ GS TP+S AGI S+LT
Sbjct: 198 GYVA-VLKKDRSNSNGVLEEPLLNGGDSRVGGDDSVELNKTNGSGEATPYSRAGILSLLT 256
Query: 232 FAWSGPLIAAGYKKTLDLEDVPQLDSRDSVIGAFPGFKEKVESDFGGINXXXXXXXXXXX 291
F+W PLI G KKTLDLEDVPQL DSV+G P F+ +ES GG
Sbjct: 257 FSWMSPLIDIGNKKTLDLEDVPQLHDTDSVVGLAPKFRSMLESPDGGERSGVTTFKLIKA 316
Query: 292 I-ISAWKEIXXXXXXXXXXXXXSYVGPYLIDGFVQYLDGQ 330
+ +A EI SYVGP LID FVQYL+G+
Sbjct: 317 LYFTAQWEILVTAFFAFIYTVASYVGPALIDTFVQYLNGR 356
>AT3G13080.3 | Symbols: ATMRP3, MRP3, ABCC3 | multidrug
resistance-associated protein 3 | chr3:4197606-4201250
REVERSE LENGTH=1120
Length = 1120
Score = 169 bits (427), Expect = 3e-42, Method: Compositional matrix adjust.
Identities = 123/340 (36%), Positives = 165/340 (48%), Gaps = 24/340 (7%)
Query: 4 ATGFFLEPXXXXXXXXXXXXXXXVAVFASWVWNKFTSYASSSAKVDGG--GSKEKTNNTL 61
+ F L+P + +F SWV K + D G S + +
Sbjct: 28 SRSFLLKPLFLRWLSGFLHSVLLLVLFFSWVRKKI--------RGDSGVTESLKDRRDFG 79
Query: 62 FSVTLFCSLGVSXXXXXXXXXXXXXWYSNGW-SEEKLVTLLDLALKMVAWGVVCACFLKG 120
F LFCSL +S WY +GW E+LV+ L L MV+WGV+ C +
Sbjct: 80 FKSALFCSLALSLLNLVLMSLSGFYWYESGWLDNEQLVSSLGFLLGMVSWGVLSICLHRC 139
Query: 121 FS---RRFPFFLFRIWCGFFLFVSCYCFAVDVVVICEKDTALPPQHVVSDVVSAIVGLFF 177
++ PF L R+W F+L VSCY VD V+ ++T +P +V D+V+ I +F
Sbjct: 140 RDCEHKKAPFLL-RLWLVFYLVVSCYSLVVDFVMYERRET-VPVHLLVFDIVAFIAAVFL 197
Query: 178 CCVGFVLKNEGGGGSNSVHEPLLKG-DSQVGNG-----KESKGSDTVTPFSSAGIFSILT 231
V VLK + + + EPLL G DS+VG ++ GS TP+S AGI S+LT
Sbjct: 198 GYVA-VLKKDRSNSNGVLEEPLLNGGDSRVGGDDSVELNKTNGSGEATPYSRAGILSLLT 256
Query: 232 FAWSGPLIAAGYKKTLDLEDVPQLDSRDSVIGAFPGFKEKVESDFGGINXXXXXXXXXXX 291
F+W PLI G KKTLDLEDVPQL DSV+G P F+ +ES GG
Sbjct: 257 FSWMSPLIDIGNKKTLDLEDVPQLHDTDSVVGLAPKFRSMLESPDGGERSGVTTFKLIKA 316
Query: 292 I-ISAWKEIXXXXXXXXXXXXXSYVGPYLIDGFVQYLDGQ 330
+ +A EI SYVGP LID FVQYL+G+
Sbjct: 317 LYFTAQWEILVTAFFAFIYTVASYVGPALIDTFVQYLNGR 356
>AT3G13080.1 | Symbols: ATMRP3, MRP3, ABCC3 | multidrug
resistance-associated protein 3 | chr3:4196019-4201250
REVERSE LENGTH=1514
Length = 1514
Score = 168 bits (426), Expect = 4e-42, Method: Compositional matrix adjust.
Identities = 122/340 (35%), Positives = 165/340 (48%), Gaps = 24/340 (7%)
Query: 4 ATGFFLEPXXXXXXXXXXXXXXXVAVFASWVWNKFTSYASSSAKVDGGGSKEKTNNTLF- 62
+ F L+P + +F SWV K + D G ++ + F
Sbjct: 28 SRSFLLKPLFLRWLSGFLHSVLLLVLFFSWVRKKI--------RGDSGVTESLKDRRDFG 79
Query: 63 -SVTLFCSLGVSXXXXXXXXXXXXXWYSNGW-SEEKLVTLLDLALKMVAWGVVCACFLKG 120
LFCSL +S WY +GW E+LV+ L L MV+WGV+ C +
Sbjct: 80 FKSALFCSLALSLLNLVLMSLSGFYWYESGWLDNEQLVSSLGFLLGMVSWGVLSICLHRC 139
Query: 121 FS---RRFPFFLFRIWCGFFLFVSCYCFAVDVVVICEKDTALPPQHVVSDVVSAIVGLFF 177
++ PF L R+W F+L VSCY VD V+ ++T +P +V D+V+ I +F
Sbjct: 140 RDCEHKKAPFLL-RLWLVFYLVVSCYSLVVDFVMYERRET-VPVHLLVFDIVAFIAAVFL 197
Query: 178 CCVGFVLKNEGGGGSNSVHEPLLKG-DSQVGNG-----KESKGSDTVTPFSSAGIFSILT 231
V VLK + + + EPLL G DS+VG ++ GS TP+S AGI S+LT
Sbjct: 198 GYVA-VLKKDRSNSNGVLEEPLLNGGDSRVGGDDSVELNKTNGSGEATPYSRAGILSLLT 256
Query: 232 FAWSGPLIAAGYKKTLDLEDVPQLDSRDSVIGAFPGFKEKVESDFGGINXXXXXXXXXXX 291
F+W PLI G KKTLDLEDVPQL DSV+G P F+ +ES GG
Sbjct: 257 FSWMSPLIDIGNKKTLDLEDVPQLHDTDSVVGLAPKFRSMLESPDGGERSGVTTFKLIKA 316
Query: 292 I-ISAWKEIXXXXXXXXXXXXXSYVGPYLIDGFVQYLDGQ 330
+ +A EI SYVGP LID FVQYL+G+
Sbjct: 317 LYFTAQWEILVTAFFAFIYTVASYVGPALIDTFVQYLNGR 356
>AT3G13080.2 | Symbols: ATMRP3, MRP3, ABCC3 | multidrug
resistance-associated protein 3 | chr3:4196019-4201250
REVERSE LENGTH=1489
Length = 1489
Score = 168 bits (426), Expect = 4e-42, Method: Compositional matrix adjust.
Identities = 122/340 (35%), Positives = 165/340 (48%), Gaps = 24/340 (7%)
Query: 4 ATGFFLEPXXXXXXXXXXXXXXXVAVFASWVWNKFTSYASSSAKVDGGGSKEKTNNTLF- 62
+ F L+P + +F SWV K + D G ++ + F
Sbjct: 28 SRSFLLKPLFLRWLSGFLHSVLLLVLFFSWVRKKI--------RGDSGVTESLKDRRDFG 79
Query: 63 -SVTLFCSLGVSXXXXXXXXXXXXXWYSNGW-SEEKLVTLLDLALKMVAWGVVCACFLKG 120
LFCSL +S WY +GW E+LV+ L L MV+WGV+ C +
Sbjct: 80 FKSALFCSLALSLLNLVLMSLSGFYWYESGWLDNEQLVSSLGFLLGMVSWGVLSICLHRC 139
Query: 121 FS---RRFPFFLFRIWCGFFLFVSCYCFAVDVVVICEKDTALPPQHVVSDVVSAIVGLFF 177
++ PF L R+W F+L VSCY VD V+ ++T +P +V D+V+ I +F
Sbjct: 140 RDCEHKKAPFLL-RLWLVFYLVVSCYSLVVDFVMYERRET-VPVHLLVFDIVAFIAAVFL 197
Query: 178 CCVGFVLKNEGGGGSNSVHEPLLKG-DSQVGNG-----KESKGSDTVTPFSSAGIFSILT 231
V VLK + + + EPLL G DS+VG ++ GS TP+S AGI S+LT
Sbjct: 198 GYVA-VLKKDRSNSNGVLEEPLLNGGDSRVGGDDSVELNKTNGSGEATPYSRAGILSLLT 256
Query: 232 FAWSGPLIAAGYKKTLDLEDVPQLDSRDSVIGAFPGFKEKVESDFGGINXXXXXXXXXXX 291
F+W PLI G KKTLDLEDVPQL DSV+G P F+ +ES GG
Sbjct: 257 FSWMSPLIDIGNKKTLDLEDVPQLHDTDSVVGLAPKFRSMLESPDGGERSGVTTFKLIKA 316
Query: 292 I-ISAWKEIXXXXXXXXXXXXXSYVGPYLIDGFVQYLDGQ 330
+ +A EI SYVGP LID FVQYL+G+
Sbjct: 317 LYFTAQWEILVTAFFAFIYTVASYVGPALIDTFVQYLNGR 356
>AT3G13090.1 | Symbols: ATMRP8, ABCC6, MRP8 | multidrug
resistance-associated protein 8 | chr3:4203013-4208171
REVERSE LENGTH=1466
Length = 1466
Score = 139 bits (349), Expect = 4e-33, Method: Compositional matrix adjust.
Identities = 94/305 (30%), Positives = 138/305 (45%), Gaps = 26/305 (8%)
Query: 32 SWVWNKFTSYASSSAKVDGGGSKEKTNNTLFS---VTLFCSLGVSXXXXXXXXXXXXXWY 88
SW++ K + + A ++ E+ + FS + L C + +S W+
Sbjct: 33 SWLFKKRVACEDTDAIMN-----EEFKHISFSYNKLVLICCVSLSVFYSVLSLLSCLHWH 87
Query: 89 SNGWSEEKLVTLLDLALKMVAWGVVCACFLKGFS---RRFPFFLFRIWCGFFLFVSCYCF 145
+NGW LDL L + WG + ++ + FL R+W FF VSCY
Sbjct: 88 TNGWP------FLDLLLAALTWGSISVYLFGRYTNSCEQKVLFLLRVWWVFFFVVSCYHL 141
Query: 146 AVDVVVICEKDTALPPQHVVSDVVSAIVGLFFCCVGFVLKNEGGGGSNSVHEPLLKGDSQ 205
VD V + +K + V+SD+V GLF CC K EG + + EPLL
Sbjct: 142 VVDFV-LYKKQEMVSVHFVISDLVGVCAGLFLCCSCLWKKGEGER-IDLLKEPLL----- 194
Query: 206 VGNGKESKGSDTVTPFSSAGIFSILTFAWSGPLIAAGYKKTLDLEDVPQLDSRDSVIGAF 265
+ + S + PFS AGI S ++F+W PLI G +K +D++DVPQLD D+ F
Sbjct: 195 -SSAESSDNEEVTAPFSKAGILSRMSFSWMSPLITLGNEKIIDIKDVPQLDRSDTTESLF 253
Query: 266 PGFKEKVESDFGGINXXXXXXXXXXXIISAWKEIXXXXXXXXXXXXXSYVGPYLIDGFVQ 325
F+ K+E D G +S W++I YV PYL+D FVQ
Sbjct: 254 WIFRSKLEWD-DGERRITTFKLIKALFLSVWRDIVLSALLAFVYTVSCYVAPYLMDNFVQ 312
Query: 326 YLDGQ 330
YL+G
Sbjct: 313 YLNGN 317
>AT3G13100.1 | Symbols: ATMRP7, MRP7, ABCC7 | multidrug
resistance-associated protein 7 | chr3:4208859-4214173
REVERSE LENGTH=1493
Length = 1493
Score = 125 bits (313), Expect = 5e-29, Method: Composition-based stats.
Identities = 81/260 (31%), Positives = 123/260 (47%), Gaps = 29/260 (11%)
Query: 88 YSNGWSEEKLVTLLDLALKMVAWGVVC----ACFLKGFSRRFPFFLFRIWCGFFLFVSCY 143
+ NGW +L+ LLDL ++WG + + F ++FP L R+W + SCY
Sbjct: 93 HKNGWDRSELMILLDLLFTALSWGAISFYIRSQFTYSHDQKFPILL-RVWWVLYFMFSCY 151
Query: 144 CFAVDVVVICEKDTALPPQHVVSDVVSAIVGLFFCCVGFVLKNEGGG------------- 190
VD+ + +K + ++SDV++ VGLF C L+ +G G
Sbjct: 152 RLLVDIALY-KKQELVSVHLLLSDVLAVSVGLFLCYS--CLQKQGQGERINLLLEEPLLN 208
Query: 191 GSNSVHEPLLKGDSQVGNGKESKGSDTVTPFSSAGIFSILTFAWSGPLIAAGYKKTLDLE 250
G+ S ++ D +++ + VTPFS+AG S ++F+W PLI G +K +D E
Sbjct: 209 GAESSAATSVQLD-------KAEDDEVVTPFSNAGFLSHVSFSWMSPLIVLGNEKIIDSE 261
Query: 251 DVPQLDSRDSVIGAFPGFKEKVESDFGGINXXXXXXXXXXXIISAWKEIXXXXXXXXXXX 310
DVPQ+D+ D F F+ K+E D G S W++I
Sbjct: 262 DVPQVDNSDRAEKLFWIFRSKLEWD-DGERRITTYKLIKALFFSVWRDILLSTLFAFVYT 320
Query: 311 XXSYVGPYLIDGFVQYLDGQ 330
YV PYL+D FVQYL+GQ
Sbjct: 321 VSCYVAPYLMDTFVQYLNGQ 340
>AT3G60160.1 | Symbols: ATMRP9, MRP9, ABCC9 | multidrug
resistance-associated protein 9 | chr3:22223829-22229195
REVERSE LENGTH=1506
Length = 1506
Score = 80.9 bits (198), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 66/229 (28%), Positives = 98/229 (42%), Gaps = 24/229 (10%)
Query: 109 AWGVVCACFLKGFSRR---FPFFLFRIW-CGFFLFVSCYCFAVDVVVICEKDTALPPQHV 164
+W V +K RR FP+ L W C F L F+ D I K L Q
Sbjct: 128 SWLFVSVVVVKIRERRLVKFPWMLRSWWLCSFIL-----SFSFDAHFITAKHEPLEFQDY 182
Query: 165 VSDVVSAIVGLFFCCV------GFVLKNEGGGGSNSVHEPLLKGDSQVGNGKESKGSDTV 218
+D+ + LF V GF L G EPLL GD N K+S S +
Sbjct: 183 -ADLTGLLASLFLLAVSIRGKTGFHLLESSGNT-----EPLLLGDQTEQNKKDSYSSSS- 235
Query: 219 TPFSSAGIFSILTFAWSGPLIAAGYKKTLDLEDVPQLDSRDSVIGAFPGFKEKVESDFGG 278
P+ +A +F +TF+W PL + GYK+ L+ +DVP +D +DS F +K+++
Sbjct: 236 -PYGNATLFQRITFSWINPLFSLGYKRPLEKDDVPDIDVKDSARFCSHAFDQKLKTT-KE 293
Query: 279 INXXXXXXXXXXXIISAWKEIXXXXXXXXXXXXXSYVGPYLIDGFVQYL 327
+ W++ +Y+GPYLI+ FV++L
Sbjct: 294 KEGPGNAFFYNSVLRYVWRKAAINAVFAVVNASTAYIGPYLINDFVEFL 342
>AT1G04120.1 | Symbols: ATMRP5, MRP5, ATABCC5, ABCC5 | multidrug
resistance-associated protein 5 | chr1:1064848-1070396
REVERSE LENGTH=1514
Length = 1514
Score = 80.5 bits (197), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 66/215 (30%), Positives = 99/215 (46%), Gaps = 20/215 (9%)
Query: 122 SRRFPFFLFRIWCGFFLFVSCYC-FAVDVVVICEKDTALPPQHVVSDVVSAIVGLFFCCV 180
S + PF L RIW F F C C VD + + + HVV+++ F C +
Sbjct: 138 SEKLPF-LVRIWW-FLAFSICLCTMYVDGRRLAIEGWSRCSSHVVANLAVTPALGFLCFL 195
Query: 181 GF--VLKNEGGGGSNSVHEPLLKGDSQVGNGKESKGSDTVTPFSSAGIFSILTFAWSGPL 238
+ V + S+ + EPLL +E VTP+S+AG+ S++T +W PL
Sbjct: 196 AWRGVSGIQVTRSSSDLQEPLLV--------EEEAACLKVTPYSTAGLVSLITLSWLDPL 247
Query: 239 IAAGYKKTLDLEDVPQLDSRDSVIGAFPGFK---EKVESDFGGINXXXXXXXXXXXIISA 295
++AG K+ L+L+D+P L RD ++ K ++ +S+ N + S
Sbjct: 248 LSAGSKRPLELKDIPLLAPRDRAKSSYKVLKSNWKRCKSE----NPSKPPSLARAIMKSF 303
Query: 296 WKEIXXXXXXXXXXXXXSYVGPYLIDGFVQYLDGQ 330
WKE SYVGPYLI FV YL G+
Sbjct: 304 WKEAACNAVFAGLNTLVSYVGPYLISYFVDYLGGK 338
>AT1G04120.2 | Symbols: MRP5 | multidrug resistance-associated
protein 5 | chr1:1064848-1070396 REVERSE LENGTH=1509
Length = 1509
Score = 80.5 bits (197), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 66/215 (30%), Positives = 99/215 (46%), Gaps = 20/215 (9%)
Query: 122 SRRFPFFLFRIWCGFFLFVSCYC-FAVDVVVICEKDTALPPQHVVSDVVSAIVGLFFCCV 180
S + PF L RIW F F C C VD + + + HVV+++ F C +
Sbjct: 138 SEKLPF-LVRIWW-FLAFSICLCTMYVDGRRLAIEGWSRCSSHVVANLAVTPALGFLCFL 195
Query: 181 GF--VLKNEGGGGSNSVHEPLLKGDSQVGNGKESKGSDTVTPFSSAGIFSILTFAWSGPL 238
+ V + S+ + EPLL +E VTP+S+AG+ S++T +W PL
Sbjct: 196 AWRGVSGIQVTRSSSDLQEPLLV--------EEEAACLKVTPYSTAGLVSLITLSWLDPL 247
Query: 239 IAAGYKKTLDLEDVPQLDSRDSVIGAFPGFK---EKVESDFGGINXXXXXXXXXXXIISA 295
++AG K+ L+L+D+P L RD ++ K ++ +S+ N + S
Sbjct: 248 LSAGSKRPLELKDIPLLAPRDRAKSSYKVLKSNWKRCKSE----NPSKPPSLARAIMKSF 303
Query: 296 WKEIXXXXXXXXXXXXXSYVGPYLIDGFVQYLDGQ 330
WKE SYVGPYLI FV YL G+
Sbjct: 304 WKEAACNAVFAGLNTLVSYVGPYLISYFVDYLGGK 338
>AT3G59140.1 | Symbols: ATMRP14, MRP14, ABCC10 | multidrug
resistance-associated protein 14 |
chr3:21863519-21868701 REVERSE LENGTH=1453
Length = 1453
Score = 61.6 bits (148), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 36/141 (25%), Positives = 63/141 (44%), Gaps = 1/141 (0%)
Query: 190 GGSNSVHEPLLKGDSQVGNGKESKGSDTVTPFSSAGIFSILTFAWSGPLIAAGYKKTLDL 249
G +S++EPL GDS G +++ + V+ F+ AG+FS L+F W LI G K L+
Sbjct: 177 SGESSLYEPLNAGDSN-GFSEKADFDNRVSQFAKAGLFSTLSFWWLNSLIKRGNVKDLEE 235
Query: 250 EDVPQLDSRDSVIGAFPGFKEKVESDFGGINXXXXXXXXXXXIISAWKEIXXXXXXXXXX 309
ED+P+L + + F+E + + ++ W+E+
Sbjct: 236 EDIPELRKEERAETCYSLFEENLIEQKRRLGSSCQPSILKVTVLCVWRELLTSGFFAFMK 295
Query: 310 XXXSYVGPYLIDGFVQYLDGQ 330
GP L++ F+ +G
Sbjct: 296 IVAVSAGPLLLNAFILVAEGN 316
>AT2G47800.1 | Symbols: ATMRP4, EST3, MRP4, ABCC4 | multidrug
resistance-associated protein 4 | chr2:19574944-19580383
FORWARD LENGTH=1516
Length = 1516
Score = 50.1 bits (118), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 35/118 (29%), Positives = 48/118 (40%), Gaps = 4/118 (3%)
Query: 213 KGSDTVTPFSSAGIFSILTFAWSGPLIAAGYKKTLDLEDVPQLDSRDSVIGAFPGFKEKV 272
+ SD V+ ++SA +FS + W PL++ GYK L LE VP L F
Sbjct: 244 EKSDNVSLYASASVFSKTFWLWMNPLLSKGYKSPLTLEQVPTLSPEHKAERLALLF---- 299
Query: 273 ESDFGGINXXXXXXXXXXXIISAWKEIXXXXXXXXXXXXXSYVGPYLIDGFVQYLDGQ 330
ES + + + WKEI YVGP LI FV + G+
Sbjct: 300 ESSWPKPSENSSHPIRTTLLRCFWKEILFTAILAIVRLGVMYVGPVLIQSFVDFTSGK 357